Aurobindo Pharma receives USFDA approval for valganciclovir
Aurobindo Pharma has received final USFDA approval to manufacture and market valganciclovir tablets USP, 450 mg. This product is to be launched in Q1 FY16-17. […]
Aurobindo Pharma has received final USFDA approval to manufacture and market valganciclovir tablets USP, 450 mg. This product is to be launched in Q1 FY16-17. […]
Cadila Healthcare has received USFDA approval for its anti-viral generic drug Acyclovir capsules Acyclovir capsules to market the same in the American market. The drug […]
Parenteral Drugs has relocated its manufacturing plant at Village Asrawad, Post Dudhia, Nemawar Road, dist. Indore to Village Panwa, Tehsil Kasrawad, dist. Khargone. The company […]
Dr. Reddys Laboratories through its subsidiary Promius Pharma has received USFDA approval to market Sernivo spray, used in treatment of skin disorder. The drug Sernivo […]
Orchid Pharma has received final USFDA approval for its generic version of rasagiline tablets used in the treatment of Parkinson’s disease. The company expects to […]
Aurobindo Pharma has received final USFDA approval to manufacture and market pre- surgery sedation injections Dexmedetomidine Hydrochloride in 200 mcg (base)/2 mL (100 mcg (base)/mL) […]
Aurobindo Pharma has received final USFDA approval to manufacture and market Levofloxacin injection, an anti-infective used in the treatment of bacterial infection in adults in […]
Biocon has received its first generic formulation approval in Europe to launch Rosuvastatin calcium tablets in several European countries. The product will be produced in […]
Glenmark Pharmaceuticals has received the final USFDA approval for its generic oral contraceptive norgestimate ethinyl estradiol tablets. in strengths of 0.18 mg/0.025 mg, 0.215 mg/ […]
Zydus Cadila has received final USFDA approval to sell anti-diabetics Glyburide and Metformin Hcl tablets in in strengths of 1.25/250, 2.5/500 and 5/500 mg in […]
Copyright © 2024 | WordPress Theme by MH Themes